329
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Serum prolidase enzyme activity and oxidative stress levels in patients with acute hemorrhagic stroke

, , , , , , & show all
Pages 199-205 | Received 23 Aug 2013, Accepted 07 Dec 2013, Published online: 23 Jan 2014

References

  • Dennis MS. Outcome after brain haemorrhage. Cerebrovasc Dis 2003;16:9–13.
  • Adams H, Bendixen B, Kappelle L, Biller J, Love B, Gordon D, Marsh E. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial.TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24(1):35–41.
  • Demirdögen BC, Demirkaya S, Türkanoglu A, Bek S, Arinç E, Adali O. Analysis of paraoxonase 1 (PON1) genetic polymorphisms and activities as risk factors for ischemic stroke in Turkish population. Cell Biochem Funct 2009;27:558–67.
  • Ames BN, Shigenega MT, Hagen M. Oxidants, antioxidants and the degenerative diseases of aging, Proc Natl Acad Sci USA 1993;90:7915–22.
  • Love S. Oxidative stress in brain ischaemia. Brain Pathol 1999;9:119–31.
  • Braughler JM, Duncan LA, Chase RL. The involvement of iron in lipid peroxidation. J Biol Chem 1986;261:10282–9.
  • Hall NC, Packard BA, Hall CL, de Courten-Myers G, Wagner KR. Protein oxidation and enzyme susceptibility in white and gray matter with in vitro oxidative stress: relevance to brain injury from intracerebral hemorrhage. Cell Mol Biol (Noisy-le-grand) 2000;46(3):673–83.
  • Peeling J, Yan HJ, Chen SG, Campbell M, Del Bigio MR. Protective effects of free radical inhibitors in intracerebral hemorrhage in rat. Brain Res 1998;795:63–70.
  • Gläsker S, Schatlo B, Klingler JH, Braun V, Spangenberg P, Kim IS, van Velthoven V, Zentner J, Neumann HP. Associations of Collagen Type I α2 polymorphisms with the presence of ıntracranial aneurysms in patients from Germany. J Stroke Cerebrovasc Dis 2014;23:356–60.
  • Carrasco FH, Montes GS, Krisztan RM, Shigihara KM, Carneiro J, Junqueira LC. Comparative morphologic and histochemical studies on the collagen of vertebrate arteries. Blood Vessels 1981;18:296–302.
  • Surazynski A, Miltyk W, Palka J, Phang JM. Prolidase dependent regulation of collagen biosynthesis. Amino Acids 2008b;35:731–8.
  • Myara I, Charpentier C, Lemonnier A. Prolidase and prolidase deficiency. Life Sci 1984;34:1985–98.
  • Palka JA, Phang JM. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem 1997;67:166–75.
  • Myara I, Myara A, Mangeot M, Fabre M, Charpentier C, Lemonnier A. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem 1984;30:211–5.
  • Erbagci AB, Araz M, Erbagci A, Tarakcioglu M, Namiduru ES. Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clin Biochem 2002;35:263–8.
  • Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int 2007;27:339–44.
  • Gejyo F, Kishore BK, Arakawa M. Prolidase and prolinase activities in the erythrocytes of patients with chronic uremia. Nephron 1983;35:58–61.
  • Aslan M, Nazligul Y, Horoz M, Bolukbas C, Bolukbas FF, Aksoy N, Celik H, Erel O. Serum prolidase activity and oxidative status in Helicobacter pylori infection. Clin Biochem 2007;40:37–40.
  • Bas DF, Topcuoglu MA, Gursoy-Ozdemir Y, Saatci I, Bodur E, Dalkara T. Plasma 3-nitrotyrosine estimates the reperfusion-induced cerebrovascular stress, whereas matrix metalloproteinases mainly reflect plasma activity: a study in patients treated with thrombolysis or endovascular recanalization. J Neurochem 2012;123:138–47.
  • Gasche Y, Copin JC, Sugawara T, Fujimura M, Chan PH. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2001;21:1393–400.
  • Grossetete M, Rosenberg GA. Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse. J Cereb Blood Flow Metab 2008;28:752–63.
  • Teasdale G, Jenett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974;2:81–3.
  • Morgenstern LB, Hemphill JC III, Anderson C, Becker K, Broderick JP, Connolly ES Jr, Greenberg SM, Huang JN, MacDonald RL, Messé SR, Mitchell PH, Selim M, Tamargo RJ. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010:41:2108–129.
  • Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112–9.
  • Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103–1.
  • Bolukbas C, Bolukbas FF, Horoz M, Aslan M, Celik H, Erel O. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis 2005;5:95–101.
  • Aebi H. Catalase. In: Bergmeyer HU (ed.). Methods of enzymatic analysis. New York and London: Academic Pres Inc.; 1974: 673–7.
  • Myara I, Myara A, Mangeot M, Fabre M, Charpentier C, Lemonnier A. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem 1984;30:211–5.
  • Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by proline colorimetric determination: application to imminodipeptiduria. Clin Chim Acta 1982;125:193–205.
  • Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem 1952;199:91–5.
  • Tracey WR, Tse J, Carter G. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther 1995;272:1011–5.
  • Cherubini A, Ruggiero C, Polidori MC, Mecocci P. Potential markers of oxidative stress in stroke. Free Radic Biol Med 2005;39:841–52.
  • Aronowski J, Hall CE. New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies. Neurol Res 2005;27:268–79.
  • Wu J, Hua Y, Keep RF, Schallert T, Hoff JT, Xi G. Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res 2002;953:45–52.
  • Katsu M, Niizuma K, Yoshioka H, Okami N, Sakata H, Chan PH. Hemoglobin-induced oxidative stress contributes to matrix metalloproteinase activation and blood-brain barrier dysfunction in vivo. J Cereb Blood Flow Metab 2010;30:1939–50.
  • Aygul R, Demircan B, Erdem F, Ulvi H, Yildirim A, Demirbas F. Plasma values of oxidants and antioxidants in acute brain hemorrhage: role of free radicals in the development of brain injury. Biol Trace Elem Res. 2005;108: 43–52.
  • Nakamura T, Keep RF, Hua Y, Nagao S, Hoff JT, Xi G. Iron-induced oxidative brain injury after experimental intracerebral hemorrhage. Acta Neurochir Suppl 2006; 96:194–8.
  • Evrenkaya TR, Atasoyu EM, Kara M, Unver S, Gultepe M. The role of prolidase activity in the diagnosis of uremic bone disease. Ren Fail 2006;28:271–4.
  • Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, Aksoy N, Ocak AR, Erel O. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis 2008;19: 319–25.
  • Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87:1620–4.
  • Rubbo H, Darley-Usmar V, Freeman BA. Nitric oxide regulation of tissue free radical injury. Chem Res Toxicol 1996;9:809–20.
  • Dalkara T, Endres M, Moskowitz MA. Mechanisms of NO neurotoxicity. Prog Brain Res 1998;118:231–9.
  • Tsuruda T, Costello-Boerrigter LC, Burnett JC Jr. Matrix metalloproteinases: pathways of induction by bioactive molecules. Heart Fail Rev 2004;9:53–61.
  • Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5:2145–54.
  • Rosenberg GA, Navratil M, Barone F, Feuerstein G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 1996;16: 360–6.
  • Gasche Y, Fujimura M, Morita-Fujimura Y, Copin J-C, Kawase M, Massengale J, Chan PH. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab 1999;19:1020–8.
  • Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Fini ME, Lo EH. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001;21:7724–32.
  • Rosell A, Cuadrado E, Ortega-Aznar A, Hernandez- Guillamon M, Lo EH, Montaner J. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 2008;39:1121–6.
  • Montaner J, Alvarez-Sabin J, Molina C, Angles A, Abilleira S, Arenillas J, Monasterio J. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 2001;32:1759–66.
  • Lewen A, Matz P, Chan PH. Free radical pathways in CNS injury. J Neurotrauma 2000;17:871–90.
  • Yong VW, Power C, Forsyth P, Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001;2:502–11.
  • Gasche Y, Copin JC, Sugawara T, Fujimura M, Chan PH. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2001;21:1393–400.
  • Jian Liu K, Rosenberg GA. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol Med 2005;39:71–80.
  • Begenik H, Soyoral YU, Erkoc R, Emre H, Taskın A, Tasdemir M, Aslan M. Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome. Redox Rep 2013;18:107–12.
  • Wayner DD, Burton GW, Ingold KU, Barclay LR, Locke SJ. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 1987;924:408–19.
  • Miyazawa T. Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radical Biol Med 1989;7:209–17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.